Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:approves |
gptkb:2013
gptkb:European_Medicines_Agency gptkb:U._S._Food_and_Drug_Administration |
| gptkbp:clinical_trial |
Phase III trials
|
| gptkbp:developed_by |
gptkb:Novartis
|
| gptkbp:dosage_form |
suspension for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bexsero
|
| gptkbp:is_recommended_for |
infants and adolescents
|
| gptkbp:marketed_as |
multiple countries
|
| gptkbp:route_of_administration |
intramuscular injection
|
| gptkbp:side_effect |
fatigue
headache fever injection site reactions |
| gptkbp:storage |
refrigerated
|
| gptkbp:targets |
gptkb:Neisseria_meningitidis_serogroup_B
|
| gptkbp:used_for |
prevention of meningococcal disease
|
| gptkbp:bfsParent |
gptkb:GSK
|
| gptkbp:bfsLayer |
4
|